(2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-L-phenylalanyl]-2-pyrro- lidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof

The present invention includes anhydrous crystalline forms of (2S,4S)-4-fluoro-1-[4-fluoro-.beta.-(4-fluorophenyl)-L-phenylalanyl]-2-py- rrolidinecarbonitrile p-toluenesulfonic acid salt.

Web www.patentalert.com

< Mammalian galanin receptors

> System and method of assessment of the efficacy of treatment of neurological disorders using the electroencephalogram

~ 00482